Ethyl 5-bromo-1,3,4-thiadiazole-2-carboxylate, 95.0%, 25g

Isobutyl cinnamate, 95.0%, 5g

(E)-2-(4-(3-Butoxyprop-1-en-1-yl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

6-FLUOROINDOLIZINE-2-CARBOXYLIC ACID, 95%, 1g

Benzyl (S)-2-(((benzyloxy)carbonyl)amino)-4-oxobutanoate, 97%, 1g

Single-channel microliter pipette mLINE® variable, 20 to 200 µl, 1 piece

Diphenyl[4-(phenylthio)phenyl]sulfonium Hexafluorophosphate>95.0%(HPLC)(T)1g

3,5-dimethyl-2,4-imidazolidinedione, 95.0%, 1g

(S)-2-Amino-2-(p-tolyl)ethanol hydrochloride, 97.0%, 100mg

6-BROMO-2-FLUORO-3-(TRIFLUOROMETHYL)BENZALDEHYDE, 95.0%, 250mg

Ethyl 3-methyl-4-nitro-1H-pyrazole-5-carboylate, 95.0%, 5g

N-[4-(Trifluoromethyl)benzoyl]-l-methionine methylester, 1g

2-(5-phenyl-1H-pyrazol-4-yl)ethan-1-amine hydrochloride, 95.0%, 1g